US1572101053 - Common Stock
ChartMill assigns a Buy % Consensus number of 82% to CEVA. The Buy consensus is the weighted average rating of the current analysts ratings.
Date | Firm | Action | Rating |
---|---|---|---|
2024-12-23 | Northland Capital Markets | Maintains | Outperform -> Outperform |
2024-11-08 | Roth MKM | Maintains | Buy -> Buy |
2024-11-08 | Rosenblatt | Maintains | Buy -> Buy |
2024-10-31 | Rosenblatt | Maintains | Buy -> Buy |
2024-08-08 | Roth MKM | Upgrade | Neutral -> Buy |
2024-08-08 | Oppenheimer | Maintains | Outperform -> Outperform |
2024-05-10 | Roth MKM | Maintains | Neutral -> Neutral |
2024-02-13 | Rosenblatt | Reiterate | Buy -> Buy |
2023-12-07 | Rosenblatt | Reiterate | Buy -> Buy |
2023-08-11 | Barclays | Maintains | Overweight -> Overweight |
2023-08-10 | Roth MKM | Downgrade | Buy -> Neutral |
2023-08-10 | Rosenblatt | Maintains | Buy -> Buy |
2023-08-10 | Barclays | Maintains | Overweight -> Overweight |
2023-08-10 | Northland Capital Markets | Maintains | Outperform -> Outperform |
2023-05-11 | TD Cowen | Maintains | Outperform |
2023-05-11 | Roth MKM | Maintains | Buy |
2023-05-11 | Oppenheimer | Maintains | Outperform -> Outperform |
2023-05-11 | Barclays | Maintains | Overweight -> Overweight |
2023-02-17 | Barclays | Maintains | Overweight |
2023-02-16 | Rosenblatt | Reiterate | Buy |
2023-02-16 | Cowen & Co. | Maintains | Outperform |
2023-02-14 | Rosenblatt | Reiterate | Buy |
2022-11-11 | Barclays | Maintains | Overweight |
2022-11-10 | Rosenblatt | Maintains | Buy |
2022-02-16 | Rosenblatt | Upgrade | Neutral -> Buy |
2021-06-23 | Rosenblatt | Initiate | Neutral |
2021-05-11 | Barclays | Upgrade | Equal-Weight -> Overweight |
2021-05-11 | Northland Capital Markets | Upgrade | Market Perform -> Outperform |
2021-02-17 | Roth Capital | Maintains | Buy |